Aohua
Aohua is a globally-renowned medical endoscope manufacturing company.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | $117m Valuation: $800m 16.8x EV/Revenue 63.9x EV/EBITDA | IPO |
| Total Funding | 000k | ||
| CNY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 32 % | 28 % | 52 % | 11 % | 14 % | 39 % | 8 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 26 % | 13 % | 18 % | 14 % | 23 % | 26 % | 23 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 16 % | 5 % | 9 % | 3 % | 11 % | 12 % | 12 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 14 % | 22 % | 22 % | 22 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Founded in 1994 and headquartered in Shanghai, Aohua Photoelectricity Endoscope Co., Ltd. is a medical device company focused on the research, development, production, and sale of video endoscopic equipment and related consumables. The company has established itself as a notable domestic player in China's flexible electronic endoscope market, which it entered at an early stage. A significant milestone in Aohua's journey was its initial public offering on the Shanghai Stock Exchange's STAR Market on November 15, 2021, which raised ¥750 million.
The business operates by manufacturing and selling a comprehensive portfolio of endoscopy products. Its client base consists of hospitals and clinics, with products used in various clinical departments, including gastroenterology, pulmonology, ENT, gynecology, and emergency medicine. Revenue is generated from the sale of endoscope equipment, endoscopic diagnosis and treatment consumables, and maintenance services. For the full year ended December 31, 2023, the company reported sales of CNY 678.08 million. Aohua has a global marketing network that spans over 80 countries and has established R&D centers and production bases in China and an international manufacturing base in Munich.
Aohua's product lineup ranges from standard to high-definition video endoscopy systems, such as the AQ series, which feature optical image enhancement technology. The company launched China's first video endoscopy system in 2005 and has since introduced progressively advanced systems, including HD and 4K ultra-high-definition models. Beyond the main endoscopy systems, the company provides peripheral devices, surgical consumables like brushes and forceps, and also serves the veterinary market with specialized endoscopy systems. This strategy allows Aohua to offer an integrated solution for endoscopic procedures.
Keywords: medical devices, endoscopy, flexible endoscope, video endoscope, gastroenterology, pulmonology, ENT, surgical consumables, medical imaging, endoscopic diagnosis, minimally invasive, veterinary endoscopy, HD endoscopy, 4K endoscopy, endoscope manufacturer, medical equipment, healthcare technology, clinical diagnostics, endoscopic surgery, STAR market
